Sit Investment Associates’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Sit Investment Associates's AMGN Position: Q1 2026 in Review
Sit Investment Associates held its Amgen (AMGN) position steady in Q1 2026 at 410 shares worth $144K. The position accounts for ﹤0.01% of the portfolio, ranked #448.
Sit Investment Associates first reported a position in AMGN in Q2 2018 and has held it in 24 quarters since. The position peaked at $20.5M in Q3 2018. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Sit Investment Associates held 410 shares of Amgen worth $144K as of Q1 2026.
- Sit Investment Associates left its Amgen share count unchanged in Q1 2026.
- Amgen made up ﹤0.01% of Sit Investment Associates's portfolio in Q1 2026, its #448 holding.
- Sit Investment Associates first reported a position in Amgen in Q2 2018 and has held it in 24 quarters since.
- Sit Investment Associates's Amgen position peaked at $20.5M in Q3 2018.
- 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Sit Investment Associates's 13F filing for Q1 2026, filed 13 May 2026.